Organon & Co 2023 SR
The report highlights Organon's 2023 progress in advancing women's health and gender equity, noting that 70% of its Board of Directors are women. The company achieved 100% pay equity in nine major markets and helped prevent approximately 65 million unintended pregnancies through its Her Promise Access Initiative. Environmentally, Organon reduced its Scope 1 and 2 emissions by 6.6% and water usage by 6.1% against a 2020 baseline. The company also successfully reused or recycled 93% of operational waste across its manufacturing sites.
Company: Organon & Co
Sector: Health Care
Country: United States
Year: 2023
Type: SR
Pages: 10
Organon & Co
ESG Highlights
The report highlights Organon's 2023 progress in advancing women's health and gender equity, noting that 70% of its Board of Directors are women. The company achieved 100% pay equity in nine major markets and helped prevent approximately 65 million unintended pregnancies through its Her Promise Access Initiative. Environmentally, Organon reduced its Scope 1 and 2 emissions by 6.6% and water usage by 6.1% against a 2020 baseline. The company also successfully reused or recycled 93% of operational waste across its manufacturing sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management